Business and Organization NorthStar Healthcare Income, Inc., together with its consolidated subsidiaries (the Company), was formed to acquire, originate and asset manage a diversified portfolio of equity, debt and securities investments in healthcare real estate, directly or through joint ventures, with a focus on the mid-acuity senior housing sector, which the Company defines as assisted living (ALF), memory care (MCF), skilled nursing (SNF), independent living (ILF) facilities and continuing care retirement communities (CCRC), which may have independent living, assisted living, skilled nursing and memory care available on one campus. The Company also invests in other healthcare property types, including medical office buildings (MOB), hospitals, rehabilitation facilities and ancillary healthcare services businesses. The Companys investments are predominantly in the United States, but it also selectively makes international investments. The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (REIT) under the Internal Revenue Code of 1986, as amended (the Internal Revenue Code), commencing with the taxable year ended December 31, 2013. The Company conducts its operations so as to continue to qualify as a REIT for U.S. federal income tax purposes. Substantially all of the Companys business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the Operating Partnership). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are NorthStar Healthcare Income Advisor, LLC (the Prior Advisor) and NorthStar Healthcare Income OP Holdings, LLC (the Special Unit Holder), each an affiliate of the Companys sponsor. The Prior Advisor invested $1,000 in the Operating Partnership in exchange for common units and the Special Unit Holder invested $1,000 in the Operating Partnership and was issued a separate class of limited partnership units (the Special Units), which are collectively recorded as non-controlling interests on the accompanying consolidated balance sheets as of June 30, 2020 and December 31, 2019. As the Company issued shares, it contributed substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of June 30, 2020, the Companys limited partnership interest in the Operating Partnership was 99.99%. The Companys charter authorizes the issuance of up to 400.0 million shares of common stock with a par value of $0.01 per share and up to 50.0 million shares of preferred stock with a par value of $0.01 per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue. The Company completed its initial public offering (the Initial Offering) on February 2, 2015 by raising gross proceeds of $1.1 billion, including 108.6 million shares issued in its initial primary offering (the Initial Primary Offering) and 2.0 million shares issued pursuant to its distribution reinvestment plan (the DRP). In addition, the Company completed its follow-on offering (the Follow-On Offering) on January 19, 2016 by raising gross proceeds of $700.0 million, including 64.9 million shares issued in its follow-on primary offering (the Follow-on Primary Offering) and 4.2 million shares issued pursuant to the DRP. The Company refers to its Initial Primary Offering and its Follow-on Primary Offering collectively as the Primary Offering and its Initial Offering and Follow-On Offering collectively as the Offering. In December 2015, the Company registered an additional 30.0 million shares to be offered pursuant to the DRP. From inception through June 30, 2020, the Company raised total gross proceeds of $2.0 billion, including $232.6 million in DRP proceeds. The Company is externally managed and has no employees. The Company is sponsored by Colony Capital, Inc. (NYSE: CLNY) (Colony Capital or the Sponsor), which was formed as a result of the mergers of NorthStar Asset Management Group Inc.(NSAM), its prior sponsor, with Colony Capital, Inc. (Colony) and NorthStar Realty Finance Corp. (NorthStar Realty) in January 2017. Effective June 25, 2018, the Sponsor changed its name from Colony NorthStar, Inc. to Colony Capital, Inc. and its ticker symbol from CLNS to CLNY. Following the mergers, the Sponsor became an internally-managed equity REIT, with a diversified real estate and investment management platform. Colony Capital manages capital on behalf of its stockholders, as well as institutional and retail investors in private funds, non-traded and traded REITs and registered investment companies. The Companys advisor, CNI NSHC Advisors, LLC (the Advisor), is a subsidiary of Colony Capital and manages its day-to-day operations pursuant to an advisory agreement. Impact of COVID-19 At the time of preparation of the second quarter 2020 financial statements, the world is continuing to face a global pandemic, the coronavirus 2019 (COVID-19). Efforts to address the pandemic continue to significantly impact economic and financial markets globally and across all facets of industries, including real estate. Specifically, the Company's healthcare real estate business and investments have experienced a myriad of challenges, including, but not limited to, declines in resident occupancy and operating cash flows, increases in cost burden faced by operators, lease concessions sought by tenants, and a stressed market affecting real estate values in general. Most of these COVID-19 effects on the Company's business significantly impacted results of operations beginning with the three months ended June 30, 2020 and the Company anticipates these pronounced and significant effects to be sustained and continue in future periods. While the Company itself has the ability to meet its near term liquidity needs, general market concerns over credit and liquidity continue to permeate in an economic downturn environment. If a general economic downturn resulting from efforts to contain COVID-19 persists over an extended period of time, this could have a prolonged negative impact on the Company's financial condition and results of operations. At this time, as the extent and duration of the increasingly broad effects of COVID-19 on the global economy remain unclear, it is difficult for the Company to assess and estimate the impact on the Company's results of operations with any meaningful precision. Accordingly, any estimates of the effects of COVID-19 as reflected and or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Quarterly Report on Form 10-Q, and such estimates may change, the effects of which could be material.